China Universal Asset Management Co. Ltd. increased its stake in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 10.6% in the fourth quarter, according to the company in its most recent ...

We came across a bullish thesis on Sana Biotechnology, Inc. (SANA) on wallstreetbets Subreddit Page by Intrepid_Web5454. In ...

Sana Biotechnology (NasdaqGS:SANA) is a well-funded cell and gene therapy innovator. Its therapies address significant unmet needs across oncology, central nervous system (CNS) disorders ...

Short interest in Sana Biotechnology Inc (NASDAQ:SANA) increased during the last reporting period, rising from 37.10M to 50.28M. This put 46.55% of the company's publicly available shares short.

Shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $3.25, but opened at $3.15. Sana Biotechnology ...

In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA) stands against the other smid-cap stocks. As the name suggests, smid-cap stocks have a valuation ...

The focus of the presentation will be on the subgroup of patients who have received 100mg bezuclastinib for at least 48 weeks to highlight the symptomatic benefits of long-term use.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...